Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Anti-Rheumatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global anti-rheumatics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Anti-rheumatics refers to drugs used to treat different symptoms of rheumatoid arthritis. These drugs are also utilized for treating inflammatory myositis and bowel diseases, various types of cancers, and connective tissue diseases, such as systemic sclerosis (SSc), systematic lupus erythematosus (SLE), and Sjogren syndrome (SS). They can be administered orally, subcutaneously (SC) or intravenously (IV) into the body. They assist in decreasing inflammation, preventing joint damage, reducing pain and swelling, and slowing the progression of arthritis. As a result, anti-rheumatics are increasingly being prescribed by specialists like rheumatologists, gastroenterologists or dermatologists across the globe.

Anti-Rheumatics Market Trends:

Rheumatoid arthritis is an inflammatory disease that causes swelling and pain in joints. It can also damage the skin, eyes, lungs, heart, and blood vessels. Therefore, the increasing prevalence of this medical condition represents one of the primary factors catalyzing the demand for anti-rheumatics around the world. These drugs aid in preventing bone deformity and improving overall body functions. As a result, their demand is escalating among the geriatric population, which is relatively more prone to these diseases. Furthermore, the growing development in the field of biosimilars and novel biologic therapies are creating a favorable market outlook. These therapies target individual molecules and act faster compared to conventional drugs. They are usually provided in combination with the disease-modifying anti-rheumatic drug (DMARD) to patients who have not responded to other treatments. The market is also influenced by the rising awareness among the masses about the easy availability of anti-rheumatics worldwide. Other significant factors, including a considerable rise in healthcare expenditure and extensive growth in the life sciences industry, are projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-rheumatics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type, drug class, route of drug administration and distribution channel.

Breakup by Type:

  • Prescription-based Drugs
  • Over-the-Counter Drugs
     

Breakup by Drug Class:

  • Disease Modifying Anti-Rheumatics Drugs (DMARD's)
  • Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
  • Corticosteroids
  • Uric Acid Drugs
  • Others
     

Breakup by Route of Drug Administration:

  • Oral
  • Parenteral
  • Others
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen Inc., Bristol-Myers Squibb Company, Celltrion Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnsons, Pfizer Inc. and Sanofi SA.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Type, Drug Class, Route of Drug Administration, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen Inc., Bristol-Myers Squibb Company, Celltrion Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnsons, Pfizer Inc. and Sanofi SA.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global anti-rheumatics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global anti-rheumatics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of drug administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anti-rheumatics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Anti-Rheumatics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Prescription-based Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Over-the-Counter Drugs
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Drug Class
    7.1    Disease Modifying Anti-Rheumatics Drugs (DMARD's)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Corticosteroids
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Uric Acid Drugs
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Route of Drug Administration
    8.1    Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Parenteral
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    E-Commerce
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AbbVie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Amgen Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    AstraZeneca plc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Biogen Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Bristol-Myers Squibb Company
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Celltrion Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Eli Lilly and Company
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    F. Hoffmann-La Roche AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
        15.3.9    Johnson & Johnsons
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sanofi SA
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Anti-Rheumatics Market: Major Drivers and Challenges
Figure 2: Global: Anti-Rheumatics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Anti-Rheumatics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Anti-Rheumatics Market: Breakup by Type (in %), 2020
Figure 5: Global: Anti-Rheumatics Market: Breakup by Drug Class (in %), 2020
Figure 6: Global: Anti-Rheumatics Market: Breakup by Route of Drug Administration (in %), 2020
Figure 7: Global: Anti-Rheumatics Market: Breakup by Distribution Channel (in %), 2020
Figure 8: Global: Anti-Rheumatics Market: Breakup by Region (in %), 2020
Figure 9: Global: Anti-Rheumatics (Prescription-based Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Anti-Rheumatics (Prescription-based Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Anti-Rheumatics (Corticosteroids) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Anti-Rheumatics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Anti-Rheumatics (Uric Acid Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Anti-Rheumatics (Uric Acid Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Anti-Rheumatics (Other Drug Classes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Anti-Rheumatics (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Anti-Rheumatics (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Anti-Rheumatics (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Anti-Rheumatics (Parenteral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Anti-Rheumatics (Parenteral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Anti-Rheumatics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Anti-Rheumatics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Anti-Rheumatics (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Anti-Rheumatics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Anti-Rheumatics (E-Commerce) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Anti-Rheumatics (E-Commerce) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: North America: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: North America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: United States: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: United States: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Canada: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Canada: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Asia-Pacific: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Asia-Pacific: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: China: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: China: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Japan: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Japan: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: India: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: India: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: South Korea: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: South Korea: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Australia: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Australia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Indonesia: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Indonesia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Europe: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Europe: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Germany: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Germany: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: France: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: France: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: United Kingdom: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: United Kingdom: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Italy: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Italy: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Spain: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Spain: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Russia: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Russia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Latin America: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Latin America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Brazil: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Brazil: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Mexico: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Mexico: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Middle East and Africa: Anti-Rheumatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Middle East and Africa: Anti-Rheumatics Market: Breakup by Country (in %), 2020
Figure 83: Middle East and Africa: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Global: Anti-Rheumatics Industry: SWOT Analysis
Figure 85: Global: Anti-Rheumatics Industry: Value Chain Analysis
Figure 86: Global: Anti-Rheumatics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-Rheumatics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Anti-Rheumatics Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Anti-Rheumatics Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 4: Global: Anti-Rheumatics Market Forecast: Breakup by Route of Drug Administration (in Million US$), 2021-2026
Table 5: Global: Anti-Rheumatics Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Global: Anti-Rheumatics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Anti-Rheumatics Market: Competitive Structure
Table 8: Global: Anti-Rheumatics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links